查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594644

灰指甲治療市場：按治療方法、按類型 - 全球預測 2025-2030

Onychomycosis Treatment Market by Treatment (Drugs, Laser Therapy, Photodynamic Therapy), Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年灰指甲治療市場估值為19.2億美元，預計到2024年將達到20.9億美元，複合年成長率為9.14%，預計到2030年將達到35.4億美元。

灰指甲治療市場的範圍和定義包括旨在管理和治療腳趾甲和手指甲真菌感染（通常稱為甲癬）的各種治療策略和產品。對治療的需求源於與這種疾病相關的嚴重不適、美容問題和潛在併發症，推動了患者和醫療保健提供者對有效解決方案的需求。治療方法包括非處方局部藥物、處方口服抗真菌藥物和使用雷射的新型治療方法，每種治療方法都取決於感染的嚴重程度。最終用途包括私人患者、醫療機構、皮膚科專科診所等。甲癬盛行率的增加、健康意識的提高、診斷方法的技術進步以及新型治療製劑的推出對市場成長產生了重大影響。值得注意的機會在於開發更方便、更具成本效益和見效更快的藥物，以及意識和獲得治療的機會仍然有限的新興經濟體的開拓中市場。公司可以透過策略性地域多元化、聯盟和收購來利用這些機會，以加強產品系列。

主要市場統計
基準年[2023] 19.2億美元
預測年份 [2024] 20.9億美元
預測年份 [2030] 35.4億美元
複合年成長率（%） 9.14%

然而，新藥價格高、口服藥物潛在副作用、長期治療方法依從性差以及來自替代療法和傳統療法的競爭等因素對市場成長構成了挑戰。此外，監管障礙和需要大規模臨床試驗來證明有效性和安全性阻礙了產品的快速開發。需要創新和研究的領域包括改進藥物傳輸系統、提高治療效果的聯合治療以及開發解決抗真菌抗藥性的製劑。由於消費者對更有效、侵入性更小的治療方法的需求，市場動態正在動態發展。企業應專注於投資研發，利用數位和遠端醫療技術，並與研究機構合作，以保持競爭力並推動長期成長。

市場動態：快速發展的灰指甲治療市場的關鍵市場洞察

供需的動態交互作用正在改變灰指甲治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 提高皮癬菌甲癬治療產品的標準化
    • 甲癬的高盛行率主要與糖尿病有關
    • 老年人口甲癬病例增加
  • 市場限制因素
    • 替代治療方案的可用性
  • 市場機會
    • 皮癬菌試紙條檢測的研發
    • 增加臨床試驗以擴大產品系列
  • 市場挑戰
    • 藥物成功率降低

波特的五力：駕馭灰指甲治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解灰指甲治療市場的外部影響

外部宏觀環境因素在塑造灰指甲治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解灰指甲治療市場的競爭狀況

灰指甲治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣灰指甲治療市場供應商的績效評估

FPNV 定位矩陣是評估灰指甲治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了灰指甲治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對灰指甲治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 促進甲癬治療標準化
      • 甲癬的發生率很高，主要與糖尿病有關
      • 老年人甲癬病例增加
    • 抑制因素
      • 替代治療方案的可用性
    • 機會
      • 皮癬菌檢測的發展
      • 增加臨床試驗以擴大產品系列
    • 任務
      • 藥物成功率低
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依治療方式分類的灰指甲治療市場

  • 藥品
  • 雷射治療
  • 動態療法

第7章灰指甲病治療市場：按類型

  • 遠端甲下真菌病
  • 近端甲下真菌病
  • 白色淺層甲癬

第8章北美和南美甲灰指甲治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太灰指甲治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲灰指甲治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Bausch Health Companies Inc.
  • Bayer AG
  • Carise Pharmaceuticals Pvt. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories
  • Galderma SA
  • Galenus Pharma Pvt Ltd
  • Glaxo SmithKline Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services, Inc.
  • Lumenis Ltd. by Boston Scientific Corporation
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
Product Code: MRR-FD3F12D54166

The Onychomycosis Treatment Market was valued at USD 1.92 billion in 2023, expected to reach USD 2.09 billion in 2024, and is projected to grow at a CAGR of 9.14%, to USD 3.54 billion by 2030.

The scope and definition of the onychomycosis treatment market encompass various therapeutic strategies and products designed to manage and cure fungal infections of the toenails and fingernails, a condition commonly known as nail fungus. Necessity for treatment arises from the severe discomfort, cosmetic concerns, and potential complications associated with the disease, driving demand for effective solutions among both patients and healthcare providers. Applications include over-the-counter topical treatments, prescription oral antifungal medications, and newer laser-based therapies, each catering to varying severity of infection. The end-use scope includes individual patients, healthcare facilities, and specialty dermatology clinics. Market growth has been significantly influenced by the increasing prevalence of onychomycosis, greater health awareness, technological advancements in diagnostic methods, and the introduction of novel treatment formulations. Notable opportunities lie in the development of more convenient, cost-effective, and faster-acting medications, and in expanding market presence in emerging economies where awareness and access to treatment remain limited. Companies can capitalize on these opportunities through strategic geographical diversification and partnerships or acquisitions that enhance their product portfolios.

KEY MARKET STATISTICS
Base Year [2023] USD 1.92 billion
Estimated Year [2024] USD 2.09 billion
Forecast Year [2030] USD 3.54 billion
CAGR (%) 9.14%

However, market growth is challenged by factors such as the high cost of newer therapies, potential side effects of oral medications, poor adherence to lengthy treatment regimens, and competition from alternative or traditional remedies. Moreover, regulatory hurdles and the requirement for extensive clinical trials to prove efficacy and safety attributes constrain rapid product development. Areas ripe for innovation and research include the development of improved drug delivery systems, combination therapies that enhance treatment efficacy, and formulations that address antifungal resistance. The nature of the onychomycosis treatment market is dynamically evolving, driven by consumer demand for more efficient and less invasive treatment options. Businesses should focus on investing in R&D, leveraging digital and telemedicine technologies for better patient engagement, and fostering collaborations with research institutions to maintain a competitive edge and drive long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Onychomycosis Treatment Market

The Onychomycosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing standardization of dermatophytic onychomycosis therapeutics products
    • High prevalence of dermatophytic onychomycosis, mainly associated with diabetes
    • Increasing the cases of onychomycosis in geriatric population
  • Market Restraints
    • Availability of alternative treatment options
  • Market Opportunities
    • Development of dermatophyte strip tests
    • Rise of clinical trials in order to expand their product portfolio
  • Market Challenges
    • Lower successful ratio of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Onychomycosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Onychomycosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Onychomycosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Onychomycosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Onychomycosis Treatment Market

A detailed market share analysis in the Onychomycosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Onychomycosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Onychomycosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Onychomycosis Treatment Market

A strategic analysis of the Onychomycosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Onychomycosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Bausch Health Companies Inc., Bayer AG, Carise Pharmaceuticals Pvt. Ltd., Cipla Ltd, Dr. Reddys Laboratories, Galderma S.A., Galenus Pharma Pvt Ltd, Glaxo SmithKline Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Lumenis Ltd. by Boston Scientific Corporation, Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Onychomycosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Drugs, Laser Therapy, and Photodynamic Therapy.
  • Based on Type, market is studied across Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, and White Superficial Onychomycosis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing standardization of dermatophytic onychomycosis therapeutics products
      • 5.1.1.2. High prevalence of dermatophytic onychomycosis, mainly associated with diabetes
      • 5.1.1.3. Increasing the cases of onychomycosis in geriatric population
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative treatment options
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of dermatophyte strip tests
      • 5.1.3.2. Rise of clinical trials in order to expand their product portfolio
    • 5.1.4. Challenges
      • 5.1.4.1. Lower successful ratio of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Onychomycosis Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Drugs
  • 6.3. Laser Therapy
  • 6.4. Photodynamic Therapy

7. Onychomycosis Treatment Market, by Type

  • 7.1. Introduction
  • 7.2. Distal Subungual Onychomycosis
  • 7.3. Proximal Subungual Onychomycosis
  • 7.4. White Superficial Onychomycosis

8. Americas Onychomycosis Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Onychomycosis Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Onychomycosis Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bausch Health Companies Inc.
  • 2. Bayer AG
  • 3. Carise Pharmaceuticals Pvt. Ltd.
  • 4. Cipla Ltd
  • 5. Dr. Reddys Laboratories
  • 6. Galderma S.A.
  • 7. Galenus Pharma Pvt Ltd
  • 8. Glaxo SmithKline Pharmaceuticals Ltd.
  • 9. Intas Pharmaceuticals Ltd.
  • 10. Johnson & Johnson Services, Inc.
  • 11. Lumenis Ltd. by Boston Scientific Corporation
  • 12. Medimetriks Pharmaceuticals Inc.
  • 13. Moberg Pharma AB
  • 14. Novartis AG
  • 15. Pfizer Inc.

LIST OF FIGURES

  • FIGURE 1. ONYCHOMYCOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ONYCHOMYCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ONYCHOMYCOSIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY PROXIMAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY WHITE SUPERFICIAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023